Published in Eur J Clin Microbiol on April 01, 1986
Pharmacokinetics of ofloxacin after parenteral and oral administration. Antimicrob Agents Chemother (1987) 3.09
Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother (1992) 1.59
Comparative pharmacokinetics of new quinolones. Drugs (1987) 1.22
Occurrence of quinolone resistance in Staphylococcus aureus from nosocomial infection. Epidemiol Infect (1992) 0.96
Effect of dose on serum pharmacokinetics of intravenous ciprofloxacin with identification and characterization of extravascular compartments using noncompartmental and compartmental pharmacokinetic models. Antimicrob Agents Chemother (1987) 0.92
Pharmacokinetics of ciprofloxacin. Infection (1988) 0.91
Steady-state pharmacokinetics of intravenous and oral ciprofloxacin in elderly patients. Antimicrob Agents Chemother (1989) 0.88
Worldwide clinical data on efficacy and safety of ciprofloxacin. Infection (1988) 0.82
Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model. CPT Pharmacometrics Syst Pharmacol (2016) 0.80
A case study of in silico modelling of ciprofloxacin hydrochloride/metallic compound interactions. AAPS PharmSciTech (2013) 0.75
Orbital and millennial Antarctic climate variability over the past 800,000 years. Science (2007) 5.10
Gas chromatography of bacterial whole cell methanolysates; V. Fatty acid composition of Neisseriae and Moraxellae. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 2.55
Pharmacokinetics of tissue penetration of antibiotics. Rev Infect Dis (1981) 2.54
Pharmacokinetics of mezlocillin in healthy volunteers. Antimicrob Agents Chemother (1978) 2.38
Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch Intern Med (2001) 2.20
Clinical manifestations of halophilic non-cholera Vibrio infections. Lancet (1974) 2.14
Inhibition of the antibacterial activity of gentamicin by urine. J Infect Dis (1976) 1.78
Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry. Blood (1990) 1.76
The diagnostic value of sputum culture in acute pneumonia. JAMA (1975) 1.75
Crystalluria and ciprofloxacin, influence of urinary pH and hydration. Chemotherapy (1986) 1.66
Pharmacokinetics of bacampicillin compared with those of ampicillin, pivampicillin, and amoxycillin. Antimicrob Agents Chemother (1978) 1.56
Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis. Acta Pathol Microbiol Scand Suppl (1975) 1.53
Imipenem/cilastatin, an alternative treatment of pseudomonas infection in cystic fibrosis. J Antimicrob Chemother (1988) 1.48
Electron microscopical and serological characteristics associated with colony type in Moraxella nonliquefaciens. Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 1.47
Gas chromatography of bacterial whole cell methanolysates. VII. Fatty acid composition of Acinetobacter in relation to the taxonomy of Neisseriaceae. Acta Pathol Microbiol Scand Suppl (1975) 1.44
Evaluation of disinfectant inactivators. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 1.42
Kinetics of tissue penetration. Are high plasma peak concentrations or sustained levels preferable for effective antibiotic therapy? Scand J Infect Dis Suppl (1978) 1.40
Mezlocillin pharmacokinetics in patients with normal and impaired renal functions. Antimicrob Agents Chemother (1979) 1.40
[Oxidative stress in a model for experimental diabetic retinopathy: treatment with antioxidants]. Arch Soc Esp Oftalmol (2004) 1.39
Human pharmacokinetics of a sulfamethoxazole-trimethoprim combination. Acta Med Scand (1972) 1.38
Pharmacokinetics of the antibacterial combination sulfamethoxazole plus trimethoprim in patients with normal or impaired kidney function. Antibiot Chemother (1971) (1974) 1.37
Transintestinal elimination of ciprofloxacin. Chemotherapy (1990) 1.36
Pharmacokinetic comparison of oral bacampicillin and parenteral ampicillin. Antimicrob Agents Chemother (1978) 1.34
Ofloxacin: serum and skin blister fluid pharmacokinetics in the fasting and non-fasting state. J Antimicrob Chemother (1986) 1.34
DNA base composition of Gram-positive cocci. J Gen Microbiol (1971) 1.33
Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses. Am J Med (1987) 1.32
HeLa cell plasma membranes. I. 5'-Nucleotidase and ouabain-sensitive ATPase as markers for plasma membranes. J Cell Biol (1974) 1.32
Some characteristics of phospholipase C from Bacillus cereus. Eur J Biochem (1977) 1.32
Influence of food and hepatobiliary disease on the excretion of josamycin. Pharmacology (1972) 1.30
Microbiological assay of josamycin. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 1.30
Vertebral osteomyelitis. Still a diagnostic pitfall. Arch Intern Med (1976) 1.29
Overview of acylureidopenicillin pharmacokinetics. Scand J Infect Dis Suppl (1981) 1.28
Chlamydia trachomatis as a cause of acute perihepatitis associated with pelvic inflammatory disease. Br J Vener Dis (1981) 1.25
Coevolution to the edge of chaos: coupled fitness landscapes, poised states, and coevolutionary avalanches. J Theor Biol (1991) 1.22
Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob Agents Chemother (1986) 1.20
Typing of Pseudomonas aeruginosa by pyocine production. Acta Pathol Microbiol Scand (1968) 1.20
Quantitative urinalysis. Diagnosing urinary tract infection in men. JAMA (1976) 1.19
Gas chromatography of bacterial whole cell methanolysates; VI. Fatty acid composition of strains within Micrococcaceae;. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.19
Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion. Arzneimittelforschung (1979) 1.19
Pelvic inflammatory disease: etiologic studies with emphasis on chlamydial infection. Obstet Gynecol (1982) 1.19
Dose dependence of piperacillin pharmacokinetics. Chemotherapy (1982) 1.18
Extravascular penetration of highly protein-bound flucloxacillin. Antimicrob Agents Chemother (1986) 1.17
A model for life changes and illness research. Cross-cultural data from the Norwegian Navy. Arch Gen Psychiatry (1974) 1.16
Temocillin in peripheral lymph. J Antimicrob Chemother (1983) 1.14
Ground penetrating radar surveys to locate 1918 Spanish flu victims in permafrost. J Forensic Sci (2000) 1.14
Renal excretion of gentamycin in chronic pyelonephritis. Acta Med Scand (1972) 1.13
Pharmacokinetics of beta-lactam antibiotics. Scand J Infect Dis Suppl (1984) 1.12
National biosecurity approaches, plans and programmes in response to diseases in farmed aquatic animals: evolution, effectiveness and the way forward. Rev Sci Tech (2008) 1.10
Reisolation of Micrococcus mucilaginosus Migula 1900. Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 1.09
Neutron sources in the Varian Clinac 2100C/2300C medical accelerator calculated by the EGS4 code. Health Phys (1997) 1.06
Demonstration of extracellular proteolytic enzymes from Legionella species strains by using synthetic chromogenic peptide substrates. Acta Pathol Microbiol Immunol Scand B (1982) 1.06
Penicillins. Antibiot Chemother (1971) (1978) 1.06
Epidemiological markers for Pseudomonas aeruginosa. 1. Serogrouping, pyocine typing--and their interrelations. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 1.05
Assay of cefotaxime by high-pressure-liquid chromatography. Chemotherapy (1981) 1.05
The action of hormones on juvenile nasopharyngeal angiofibroma. A case report. Acta Otolaryngol (1966) 1.03
Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part I: Comparison of the antibacterial effect of sulphonamides alone and in combination with trimethoprim. Infection (1979) 1.02
Incident stroke after discharge from the hospital with a diagnosis of atrial fibrillation. Am J Med (2000) 1.02
The neurobiology of magnetoreception in vertebrate animals. Trends Neurosci (2000) 1.01
Pharmacokinetics of azlocillin in children with cystic fibrosis. Arzneimittelforschung (1979) 1.01
Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics. Scand J Infect Dis (1987) 1.00
Homogeneous climate variability across East Antarctica over the past three glacial cycles. Nature (2003) 1.00
Production and characterization of monoclonal antibodies to toxic shock syndrome toxin 1 and use of a monoclonal antibody in a rapid, one-step enzyme-linked immunosorbent assay for detection of picogram quantities of toxic shock syndrome toxin 1. J Clin Microbiol (1987) 1.00
Comparison of numerical procedures for grouping pseudomonas bacteriophages according to lytic spectra. Acta Pathol Microbiol Scand B Microbiol Immunol (1972) 0.99
Biological availability and in vitro release from oral oxytetracycline and tetracycline preparations. Acta Pharmacol Toxicol (Copenh) (1973) 0.99
Spatial vision in the purple sea urchin Strongylocentrotus purpuratus (Echinoidea). J Exp Biol (2010) 0.98
Outer membrane proteins and plasmids in different Yersinia enterocolitica serogroups isolated from man and animals. Acta Pathol Microbiol Immunol Scand B (1985) 0.98
Pharmacokinetics of bacampicillin and bacmecillinam in plasma and peripheral lymph. Lymphology (1979) 0.98
Pharmacokinetics of metronidazole in patients with enteric disease compared to normal volunteers. Chemotherapy (1981) 0.97
Legionnaires' disease combined with erythema multiforme in a 3-year-old boy. Acta Paediatr Scand (1981) 0.97
Susceptibility testing of Haemophilus influenzae--an international collaborative study in quality assessment. J Antimicrob Chemother (1996) 0.95
Analysis of nuclear fiber cell cytoplasmic texture in advanced cataractous lenses from Indian subjects using Debye-Bueche theory. Exp Eye Res (2007) 0.95
Bacterial isolates in cholecystitis and cholelithiasis. Scand J Gastroenterol (1979) 0.95
An oceanic cold reversal during the last deglaciation. Science (2001) 0.95
Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis. Chemotherapy (1980) 0.95
Lymphogranuloma venereum. A cause of cervical lymphadenopathy. JAMA (1976) 0.95
Kidney transport in man of sulfamethoxazole and trimethoprim. Chemotherapy (1972) 0.93
Distribution to human peripheral lymph of amoxycillin and of ampicillin from the oral prodrug bacampicillin. J Antimicrob Chemother (1983) 0.93
Antitubercular action of disinfectants. J Appl Bacteriol (1971) 0.93
Cross-over study of penicillin pharmacokinetics after intravenous infusions. Chemotherapy (1974) 0.93
Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim. Infection (1979) 0.91
Pharmacokinetic profile of fosfomycin trometamol. Chemotherapy (1993) 0.90
Penetration of erythromycin into human peripheral lymph. J Antimicrob Chemother (1982) 0.89
Vaginal disinfection with chlorhexidine during childbirth. Int J Antimicrob Agents (1999) 0.89
Pharmacokinetics of metronidazole in healthy adult volunteers after tablets and suppositories. Chemotherapy (1980) 0.89
Mondini cochlea in Pendred's syndrome. A histological study. Acta Otolaryngol (1986) 0.89
Human pharmacokinetics of cephalexin. Pharmacology (1970) 0.89
Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base. Br J Clin Pharmacol (1982) 0.89
Impact of ticarcillin/clavulanate on the intestinal microflora. J Antimicrob Chemother (1989) 0.89
Comparative pharmacokinetics of cefazolin, cephalothin, cephacetril, and cephapirine after intravenous administration. Chemotherapy (1977) 0.89
Effectiveness of achievable urinary concentrations of tetracyclines against "tetracycline-resistant" pathogenic bacteria. J Infect Dis (1975) 0.88
Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis. Scand J Infect Dis Suppl (1981) 0.87
Deletion mapping of the beta-glucuronidase gene. Am J Med Genet (1988) 0.87